Discovery of a Potent and Selective Inhibitor of Human NLRP3 with a Novel Binding Modality and Mechanism of Action
Kevin Wilhelmsen, Aditi Deshpande, Sarah U. Tronnes, Maitriyee Mahanta, MATTHEW BANICKI, MARY COCHRAN, Samantha Cowdin, Kristen Fortney, George D. Hartman, Robert E. Hughes, Rusty L. Montgomery, CLAUDIA PORTILLO, Paul D. Rubin, Taiz Salazar, Yan Wang, , Rebecca C. Coll
This paper characterizes BAL-0028, a novel NLRP3 inhibitor with a distinct binding site and mechanism, showing potent inhibition of human and primate NLRP3 and efficacy in a peritonitis model.
The Journal of Experimental Medicine · Jul 24, 2025Peer-reviewedImmunology